반응식
[Cl:1][C:2]1[C:3]([O:11][CH2:12][CH:13]2[CH2:15][CH2:14]2)=[CH:4][C:5]([C:8]([OH:10])=O)=[N:6][CH:7]=1.[NH2:16][C:17]1([CH2:22][OH:23])[CH2:21][CH2:20][CH2:19][CH2:18]1>>[OH:23][CH2:22][C:17]1([NH:16][C:8]([C:5]2[CH:4]=[C:3]([O:11][CH2:12][CH:13]3[CH2:15][CH2:14]3)[C:2]([Cl:1])=[CH:7][N:6]=2)=[O:10])[CH2:21][CH2:20][CH2:19][CH2:18]1참가 물질
3
실험 절차
The title compound was synthesized in analogy to Example 1, using 5-chloro-4-cyclopropylmethoxy-pyridine-2-carboxylic acid and 1-amino-cyclopentanemethanol (CAN 10316-79-7) as starting materials and isolated (40 mg, quant.) as white solid; MS (ESI, m/z): 325.1 (MH+).
후처리
- customisolated (40 mg, quant.) as white solid
출처 및 근거
- ORD 기록
- ord-69c70462415b4063b38eb9850b0debd2
- 출처 데이터셋
- uspto-grants-2016_08
- 특허 번호
- US09409866B2
연결된 노트
불러오는 중…